Stuart Dollow

Vermilion Life Sciences Ltd

Stuart is Chair of the Advisory Committee on Clinical Excellence Awards (ACCEA). He is a fully GMC registered physician, who trained in General Medicine and General Practice before gaining many years’ experience in senior leadership roles at Roche, GlaxoSmithKline, Norgine, Takeda and UCB. He is the Founder of Vermilion Life Sciences, which provides consultancy services to reduce the time and cost of medicines development to improve patient access.
Stuart is also an Authority Member of the Human Tissue Authority, a Board Trustee of the Faculty of Pharmaceutical Medicine, and has worked as an external ‘Champion'' for the UK Government''s Office for Life Sciences, Accelerated Access Review.

dont miss

Reengineering Medicines Development

Exploring opportunities to reduce the cost and time of medicines development. How patient input, digital tools and real world data in real time can facilitate adaptive licensing and early regulator and payer discussions to generate early access.

EVEN MORE SEMINARS

  • Dr Ndaba Mazibuko: Speaking at the Oncology Convention

    Dr Ndaba Mazibuko
    Care Oncology Clinic, Kings College London

    Drug Repurposing In Practice: Metabolic Pleiotropism in Glioblastoma Management

  • Professor Patricia Price: Speaking at the Oncology Convention

    Professor Patricia Price
    Action Radiotherapy

    Action Radiotherapy -a charity for radiotherapy patients and professionals.

  • Profess Liz Ward: Speaking at the Oncology Convention

    Profess Liz Ward
    Centre for Functioning and Health Research, Metro South Hospital and Health Service, and The Univers

    Laryngectomy rehabilitation: Opportunities for improving speech pathology supports via telehealth

  • Camilo Colaco: Speaking at the Oncology Convention

    Camilo Colaco
    ImmunoBiology

    The immunobiology of immunotherapy

  • Mavis Nye BCaH: Speaking at the Oncology Convention

    Mavis Nye BCaH
    Mavis Nye Foundation

    Mesothelioma